Zhu, X., Ting, Z., Duan, W., Chen, Q., Liu, J., Yu, W., Zhao, X., Qin, Y., Shi, H., Chang, Y., Huang, X., Jiang, H. (2025). Oral etoposide vs intravenous daunorubicin plus ATRA-RIF as induction therapy for low-risk acute promyelocytic leukemia: A phase II randomized controlled Trial. Blood. https://doi.org/10.1182/blood-2025-1671